• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病的病理生理学和治疗的叙述性综述。

A Narrative Review of the Pathophysiology and Treatment of Hypertrophic Cardiomyopathy.

机构信息

From the Department of Medicine, Universidad Autónoma de Guadalajara School of Medicine, Guadalajara, Jalisco, Mexico, Department of Medicine, American University of Integrative Sciences, Tucker, Georgia, Department of Medicine, University of Pittsburgh Medical Center Western Maryland Health System, Cumberland, Maryland, Tianjin Medical University, Tianjin, P.R. China, GMERS Medical College, Gandhinagar, Gujarat, India, Department of Cardiology, School of Medicine University of Missouri, Columbia, Missouri, and Department of Internal Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.

出版信息

South Med J. 2022 Dec;115(12):926-929. doi: 10.14423/SMJ.0000000000001478.

DOI:10.14423/SMJ.0000000000001478
PMID:36455903
Abstract

Hypertrophic cardiomyopathy (HCM) is a genetic autosomal dominant disorder of the heart muscle that is characterized by left ventricular hypertrophy and sudden cardiac death. It is the most common inherited cardiac disease. HCM is defined by sarcomeric mutations that result in fibrosis of the heart, affecting contraction. In most cases, clinical presentations can range from asymptomatic to systolic and diastolic ventricular dysfunction, arrhythmias, and sudden cardiac death. Some histopathologic features typical of the disease are changes in myocyte disarray and myocardial fibrosis. Mutations in the β-myosin heavy chain and myosin-binding protein C have been identified as the cause of the disease. The goals of pharmacological therapy as well as nonpharmacological therapy are to alleviate the symptoms and to prevent sudden cardiac death. Anatomical defects are treated primarily by surgical intervention, whereas other issues such as hypercontractility are treated with pharmacotherapy. In this article, we review the pathophysiology and treatment options for HCM.

摘要

肥厚型心肌病(HCM)是一种遗传性常染色体显性心脏肌肉疾病,其特征为左心室肥厚和心脏性猝死。它是最常见的遗传性心脏病。HCM 由肌节突变定义,导致心脏纤维化,影响收缩。在大多数情况下,临床表现可以从无症状到收缩和舒张心室功能障碍、心律失常和心脏性猝死不等。该疾病的一些典型组织病理学特征是肌细胞排列紊乱和心肌纤维化的改变。β-肌球蛋白重链和肌球蛋白结合蛋白 C 的突变已被确定为疾病的原因。药物治疗和非药物治疗的目标是缓解症状和预防心脏性猝死。解剖缺陷主要通过手术干预治疗,而其他问题如高收缩性则用药物治疗。在本文中,我们回顾了 HCM 的病理生理学和治疗选择。

相似文献

1
A Narrative Review of the Pathophysiology and Treatment of Hypertrophic Cardiomyopathy.肥厚型心肌病的病理生理学和治疗的叙述性综述。
South Med J. 2022 Dec;115(12):926-929. doi: 10.14423/SMJ.0000000000001478.
2
Current and emerging perspectives on pathophysiology, diagnosis, and management of hypertrophic cardiomyopathy.目前对肥厚型心肌病病理生理学、诊断和治疗的新观点。
Hellenic J Cardiol. 2023 Mar-Apr;70:65-74. doi: 10.1016/j.hjc.2022.11.002. Epub 2022 Nov 17.
3
Molecular Genetic Basis of Hypertrophic Cardiomyopathy.肥厚型心肌病的分子遗传学基础。
Circ Res. 2021 May 14;128(10):1533-1553. doi: 10.1161/CIRCRESAHA.121.318346. Epub 2021 May 13.
4
A simple algorithm for a clinical step-by-step approach in the management of hypertrophic cardiomyopathy.一种用于肥厚型心肌病管理的临床分步式方法的简单算法。
Future Cardiol. 2021 Nov;17(8):1395-1405. doi: 10.2217/fca-2020-0230. Epub 2021 Feb 22.
5
Hypertrophic cardiomyopathy.肥厚型心肌病。
Nurs Clin North Am. 2013 Dec;48(4):571-84. doi: 10.1016/j.cnur.2013.09.001.
6
Hypertrophic cardiomyopathy: evaluation and treatment of patients at high risk for sudden death.肥厚型心肌病:猝死高危患者的评估与治疗
Pacing Clin Electrophysiol. 1997 Feb;20(2 Pt 2):478-501. doi: 10.1111/j.1540-8159.1997.tb06206.x.
7
Unique Aspects of Hypertrophic Cardiomyopathy in Children.儿童肥厚型心肌病的独特方面。
Can J Cardiol. 2024 May;40(5):907-920. doi: 10.1016/j.cjca.2024.01.013. Epub 2024 Jan 18.
8
A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.β肌球蛋白重链基因中的错义突变是肥厚型心肌病患者过早猝死的一个预测指标。
J Sports Med Phys Fitness. 1994 Mar;34(1):1-10.
9
Hypertrophic Cardiomyopathy: An Overview of Genetics and Management.肥厚型心肌病:遗传学与管理概述。
Biomolecules. 2019 Dec 16;9(12):878. doi: 10.3390/biom9120878.
10
Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.肥厚型心肌病的当前观点:聚焦芬兰人群中的患者综述
Ann Med. 2016 Nov;48(7):496-508. doi: 10.1080/07853890.2016.1187764. Epub 2016 Jul 27.

引用本文的文献

1
Copper ions: The invisible killer of cardiovascular disease (Review).铜离子:心血管疾病的隐形杀手(综述)。
Mol Med Rep. 2024 Nov;30(5). doi: 10.3892/mmr.2024.13334. Epub 2024 Sep 20.